in Newswire Published on April 22, 2019

Class Action Over Quincy Bioscience’s Prevagen Brain Health Claims Transferred to New York

Spath v. Quincy Bioscience Holding Company, Inc. et al.

Filed: April 22, 2019 § 1:19-cv-03521

A class action filed in August 2018 claims Quincy Bioscience falsely misrepresented the apparent brain heath benefits of Prevagen.

Case Spotlight

Video Game Addiction Lawsuits

How Do I Join a Class Action Lawsuit?

ClassAction.org Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

Last Updated on April 22, 2019 — 4:24 PM

Corrado Rizzi

corrado@classaction.org

Corrado Rizzi is the Senior Managing Editor of ClassAction.org.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.